Dahlia Labs, Inc. — Form D
Dahlia Labs, Inc. of HILLSBOROUGH, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-24. The offering totals $18.0M, of which $18.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-06-24
- Form: D
- Accession: 0002008800-24-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $18.0M
- Amount sold: $18.0M
- Remaining: $5K
- Investors: 30
- Date of first sale: 2023-12-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-516641
Issuer
- Name: Dahlia Labs, Inc.
- CIK: 0002008800
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 2401 OAKDALE RD., HILLSBOROUGH, CA, 94010
- Phone: 206-465-1513
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Julie Bornstein | Director | Hillsborough, CA |
| Kirsten Green | Director | San Francisco, CA |
| Julie Bornstein | Executive Officer | Hillsborough, CA |
| Jon Callaghan | Director | San Francisco, CA |
| Vlad Loktev | Director | Hillsborough, CA |
Other filings by this issuer (1)
More